FolioLanternBeta
UTHRUnited Therapeutics Corp

Martine Rothblatt

Chairperson & CEO, Director at United Therapeutics Corp, as of Oct 14, 2026Sold $888M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
1.67M
shares sold, past 12 months
203
days with sales
$5.6M
largest single day, Mar 30, 2026
2
companies filed for

Share of stake sold and shares held at United Therapeutics Corp are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $20.6M under a disclosed planOctNov 2025: $36.2M under a disclosed planNovDec 2025: $28.3M under a disclosed planDecJanFebMar 2026: $111M under a disclosed planMarApr 2026: $114M under a disclosed plan$114MAprMay 2026: $109M under a disclosed planMayJun 2026: $109M under a disclosed planJunJul 2026: $112M under a disclosed planJulAug 2026: $103M under a disclosed planAugSep 2026: $98.8M under a disclosed planSepOct 2026: $46.8M under a disclosed planOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
United Therapeutics Corp (UTHR)Chairperson & CEO, DirectorAug 18, 2003Oct 14, 2026
BETA Technologies, Inc. (BETA)DirectorFeb 3, 2026Jun 12, 2026

Also a director at

BETA Technologies, Inc. (BETA)

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.